Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in
Clovis Oncology, Inc. operates as a biotechnology company. The Company focuses on acquiring, developing, and commercializing of cancer treatments. Clovis Oncology serves clients worldwide.
Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing, and commercializing anti-cancer agents in the United States
Foundation Medicine, Inc. and Clovis Oncology, Inc. (Nasdaq:CLVS) announced today that they have entered into a diagnostic collaboration. The
List of Subsidiaries of Clovis Oncology, Inc. Name: Jurisdiction of Organization: Clovis Oncology UK Limited. United Kingdom. Clovis Oncology Italy Srl. Italy.
Clovis Oncology, Inc. is a biopharmaceutical company which focuses on acquiring, developing and commercializing cancer treatments in the United States
Clovis Oncology Inc. 0.00 0. Clovis Oncology Inc. - USD 2024 Clovis Oncology Inc.
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2024 and is
Willkie represented Clovis Oncology, Inc. in the sale of its oncology drug Rubraca (rucaparib) to pharma Schweiz GmbH in a bankruptcy 363 sale.
Comments